Formulation And Evaluation Of Fast Disintegration Tablet Of Nicardipne

Abstract

The Aim Of This Study Was To Formulate And Evaluate Nicardipine Fast Disintegrating Tablets (FDTs), Which Are Designed To Provide Rapid Onset Of Action, Enhanced Bioavailability, And Improved Patient Compliance, Especially In Individuals With Swallowing Difficulties. Nicardipine, Calcium Channel Blocker, Was Selected As The Model Drug Due To Its Potent Analgesic And Anti-inflammatory Properties. The Tablets Were Formulated Using The Direct Compression Method, Which Is Cost-effective And Efficient For Mass Production. Various Excipients, Including Microcrystalline Cellulose, Crospovidone, Sodium Starch Glycolate, And Magnesium Stearate, Were Utilized To Optimize The Disintegration, Flowability, And Compression Characteristics Of The Formulation. Pre-compression Studies Were Conducted To Assess The Powder Blend’s Flowability And Compressibility, Using Parameters Such As Bulk Density, Tapped Density, Carr’s Index, Angle Of Repose, And Moisture Content. These Evaluations Indicated That The Powder Blends Had Suitable Flow Properties For Tablet Compression. Post-compression Testing, Including Hardness, Friability, Disintegration Time, And Dissolution, Demonstrated That The Prepared Tablets Met The Desired Criteria For Fast Disintegration And Drug Release. The Disintegration Time Was Found To Be Within The Required Limits For FDTs, Ensuring Rapid Release Of The Drug Upon Contact With Saliva. A Calibration Curve For Nicardipine Was Developed Using UV Spectrophotometry To Quantify Drug Content In Dissolution Studies. The Dissolution Profile Showed Rapid Release Of Nicardipine, Which Is Characteristic Of Fast-dissolving Tablets. Stability Studies Confirmed That The Tablets Were Stable Under Standard Storage Conditions, With No Significant Changes In Drug Content Or Physical Properties. In Conclusion, The Formulated Nicardipine FDTs Were Successfully Developed With Satisfactory Characteristics In Terms Of Disintegration, Dissolution, And Stability. These Tablets Offer An Efficient Alternative For The Delivery Of Nicardipine, Improving Patient Compliance And Providing Rapid Therapeutic Action. Further Studies May Explore The Optimization Of Excipients And The Effect Of Different Formulation Variables On The Performance Of The Tablets.(FTIR) Spectrum. The Solid Dispersions Can Be Evaluated By In-vitro Dissolution Studies

Keywords